Skip to content

Operating Income at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$129.64M-42.1%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$52.15M+1,073%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$2.41M+614%
XER
Xeris Biopharma Holdings, Inc.XERS
$7.92M+356%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$78.59M+7.4%
PVL
Palvella TherapeuticsPVLA
-$14.86M-88.7%

Other financials

Income statement

See full
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$132.59M-87.6%

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's operating income?
Polaryx Therapeutics, Inc. (PLYX) reported operating income of -$1.96M in Q1 2026.
How has Polaryx Therapeutics, Inc. 's operating income changed year-over-year?
Polaryx Therapeutics, Inc. 's operating income increased by 61.2% year-over-year, from -$5.05M to -$1.96M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.